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Mutations in C4orf26, Encoding a Peptide with In Vitro
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Autozygosity mapping and clonal sequencing of an Omani family identified mutations in the uncharacterized gene, C4orf26, as a cause
of recessive hypomineralized amelogenesis imperfecta (AI), a disease in which the formation of tooth enamel fails. Screening of a panel
of 57 autosomal-recessive AI-affected families identified eight further families with loss-of-function mutations in C4orf26. C4orf26
encodes a putative extracellular matrix acidic phosphoprotein expressed in the enamel organ. A mineral nucleation assay showed
that the protein’s phosphorylated C terminus has the capacity to promote nucleation of hydroxyapatite, suggesting a possible function
in enamel mineralization during amelogenesis.Mature enamel consists almost exclusively of highly orga-
nized calcium hydroxyapatite (Ca10[PO4]6[OH]2) (HA)
crystals that give teeth their key functional properties.
Enamel formation (amelogenesis) involves bio-
mineralization of an ephemeral protein extracellular
matrix secreted by ameloblasts. Failure of normal amelo-
genesis presents clinically as amelogenesis imperfecta (AI
[MIM 104530]), a genetically and phenotypically heteroge-
neous group of inherited conditions that have a prevalence
ranging from 1/700 to 1/14,0001,2 and that can have
a profoundly negative impact on affected individuals and
their families.3 Classification into hypoplastic or hypo-
mineralized AI distinguishes forms with either diminished
enamel volume or near-normal enamel volumes and poor
mineralization leading to abnormally soft enamel, respec-
tively. Mixed hypomineralized and hypoplastic pheno-
types can occur, although posteruption changes can
confound phenotype interpretation.
Understanding of the molecular pathways involved
in amelogenesis has informed the identification of genes
mutated in nonsyndromic AI; these genes include
AMELX4 (MIM 300391) and ENAM5 (MIM 606585), which
encode enamel matrix proteins, and KLK46 (MIM 603767)
and MMP207 (MIM 604629), encoding proteases that
digest enamel-matrix proteins. However, the etiology of a
large proportion of AI cases still remains to be discov-
ered.8,9 Furthermore, recent genetic studies have identified
mutations in uncharacterized genes with no clear func-
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The Americankey events in amelogenesis. Identification of additional
components of amelogenesis will provide insights into
biomineralization and will further facilitate the develop-
ment of biomimetic materials with applications for enamel
repair and skeletal-tissue engineering.17
We identified a consanguineous Omani family (AI-46)
affected by autosomal-recessive hypomineralized AI (Fig-
ure 1). Affected enamel was yellowish brown and hypo-
mineralized with partial, mild developmental enamel
hypoplasia that was prone to rapid functional failure
with posteruptive volume loss (Figure 2). DNA samples
were obtained from Oragene DNA sample collection kits
(DNA Genotek, Ontario, Canada). With informed consent,
the study was performed according to the principles of the
declaration of Helsinki after ethics approval was obtained
in the countries where the families were living.
DNA from affected individuals IV:9 and IV:10 and
an equimolar mixture of DNA from affected individuals
IV:12, IV:13, and IV:15 (Figure 1A) were subjected to
Affymetrix 6.0 SNP microarray analysis. Analysis with
AutoSNPa18 identified a shared region of homozygosity
(Figure 1B) on chromosome 4 between SNPs rs7679122
and rs17030727 (chr4: 69,820,283–101,963,249). Microsa-
tellite genotyping confirmed that all affected individuals
shared a homozygous haplotype that was not shared by
unaffected members of the family. This region encom-
passed several genes, including ENAM, implicated in
enamel biomineralization; ENAM variants are associated
with hypoplastic forms of AI. Sanger sequencing of exonicity of Leeds, LS9 7TF Leeds, UK; 2Leeds Dental Institute, University of Leeds,
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Figure 1. Identification of a Recessive AI Locus on Chromosome 4q
(A) Pedigree of family AI-46.
(B) AutoSNPa18 output for chromosome 4 for individuals IV:9 and IV:10 and an equimolar combination of DNA from IV:12, IV:13, and
IV:15. Heterozygous SNPs are highlighted in yellow, homozygous SNPs are shown in black, and chromosome position (Mb) is shown on
the left. The disease interval is marked between SNPs rs7679122 and rs17030727 (chr4: 69,820,283–101,963,249).regions and intron-exon boundaries of ENAM (MIM
606585), AMBN (MIM 601259), AMTN (MIM 610912),
and ODAM did not reveal any novel or potentially patho-
genic variation.
We designed a custom SureSelect Target Enrichment
reagent (Agilent Technologies, Edinburgh UK) targeting
coding exons within the disease interval in parallel with
the capture of disease intervals for seven other unrelated
disorders. Upon the merging of overlapping exons, a total
of 1,693 coding intervals were identified in the region
comprising 27.4 kb. We were able to target a total
of 1,684 intervals while avoiding designing baits with
homology to repeat masked sequence, leaving only
847 bp of coding sequence not targeted by the reagent.
Three micrograms of genomic DNA was processed accord-
ing to the Agilent SureSelect Library Prep protocol version
1.0.1 (October 2009). In brief, DNA was sheared and
ligated to Illumina paired-end adapters before size selec-the unerupted permanent upper canine tooth (*), which is in the p
the permanent canine there is absence of the expected contrast betwe
tent with enamel hypomineralization. Bitewing radiographs (B.ii
involving the occlusal surfaces of permanent (p) and deciduous teet
(C) Individual IV:2 (see Figure S1) from Syrian family AI-42.
(D) Individual IV:1 (see Figure S1) from Omani family AI-47.
(E) Individual II:2 (see Figure S1) from Omani family AI-51.
566 The American Journal of Human Genetics 91, 565–571, Septembtion (200–300 bp) and PCR amplification. The amplified
library was hybridized for 24 hr at 65Cwith the SureSelect
reagent, and captured DNA was selected with streptavidin-
coated magnetic beads and purified. A posthybridization
amplification step was performed before clean up with
Ampure SPRI beads (Beckman). The library was hybridized
to a single-read flow cell (Illumina, California, USA) and
sequenced for 80 cycles on an Illumina GAIIx with an
adapted single-read protocol.
Raw data files were processed by the Illumina pipeline
(version 1.3.4), and sequencing reads were aligned to the
human reference sequence (hg19) with Novoalign soft-
ware (Novocraft Technologies, Selangor, Malaysia). The re-
sulting alignment was processed in the SAM/BAM format19
with Picard and the Genome Analysis Toolkit (GATK)20,21
java programs for correcting alignments around indel sites
and marking potential PCR duplicates. After postprocess-
ing and duplicate removal, a mean depth of 112 readsFigure 2. Clinical Dental Phenotypes Due
to C4orf26 Mutations
(A) Family AI-46 from Oman. The appear-
ance is within normal limits for the hetero-
zygous (carrier) mother (A.iii) (see III:2 in
Figure S1) of the affected individuals (A.i
and A.ii) (see IV:13 and IV:12, respectively,
in Figure S1). By contrast, all the other clin-
ical images are from individuals with homo-
zygous mutations. The affected enamel is
yellowish brown and hypomineralized with
partial, mild developmental enamel hypo-
plasia. The enamel is prone to rapid func-
tional failure with posteruptive volume
loss. Dental plaque deposits (/) can be ex-
tensive, reflecting difficulties in maintain-
ing good oral hygiene as the teeth fail and
become sensitive.
(B) Individual II:4 (see Figure S1) from Iraqi
family AI-1. A dental radiograph (B.ii) illus-
trates a near-normal crown morphology for
rocess of replacing the almost exfoliated deciduous canine (x). In
en enamel and dentine radiodensity. These appearances are consis-
i) illustrate poor-quality enamel and premature enamel failure
h. Dental restorations (þ) are marked.
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with a minimum base-phred quality score of 17 and
minimum read-mapping quality of 20 was achieved for
target regions; 97% of target bases were covered by greater
than 5 such reads.
Variants within the candidate regions were called in the
variant-call format with the Unified Genotyper and
DINDEL22 functions of GATK. A total of 191 single-
nucleotide and indel variants in the target regions were
identified in or within 20 bp of coding exons in the target
region. Variants present in dbSNP129 or with a minor
allele frequency of 1% or higher were removed, as were
variants present in two or more of the seven unrelated
samples sequenced alongside the proband.
Upon filtering of common variation, only two poten-
tially pathogenic variants remained. The first, a homo-
zygous missense change (c.95C>A [p.Pro32His]; RefSeq
accession number NM_000670.3) in ADH4 (MIM
103740), was subsequently shown to be heterozygous in
affected individual IV:8 by Sanger sequencing, suggesting
a modest refinement of the candidate region. The re-
maining variant was a homozygous nonsense change
(c.229C>T [p.Arg77*]; RefSeq NM_178497.3) in the un-
characterized C4orf26 and segregated with AI in the AI-46
Omani family and was absent from 160 ethnically-
matched and 78 Pakistani control DNA samples. To
determine the population frequency of this variant, we
extracted alignment regions for C4orf26 from BAM files
at the 1000 Genomes Project23 and called genotypes.
Genotypes were confidently called (genotype phred
quality score R 30) for 1,135 individuals who were all
homozygous for the reference nucleotide.
We sequenced C4orf26 coding exons and flanking in-
tronic sequence in DNA from 57 apparently unrelated
probands who had recessive or sporadic AI and for whom
mutations in other recessive AI-associated genes had
been excluded (Figure 3). The same homozygous nonsense
variant (c.229C>T [p.Arg77*]) as identified in family AI46
was also identified in three further Omani families (AI-47,
AI-51, and AI-67 [Figure S1, available online]) and was
shown to segregate with hypomineralized AI. We found
an Iraqi family (AI-1 [Figure S1]) in which a different
homozygous nonsense change (c.129C>A [p.Cys43*])
segregated with AI. Mutation of the splice acceptor site of
exon 2 (c.68-2A>T [p.?]) was identified and shown to
segregate with AI in a Syrian family (AI-42 [Figure S1]).
Neither of these changes could be found in 110 Turkish,
50 Jordanian, or 78 Pakistani control DNA samples. The
former change (c.129C>A [p.Cys43*]) was found to be
homozygous for the reference base in 1,131 samples
(from the 1000 Genomes Project) for which the genotype
could be confidently called. Similarly, the splice-acceptor-
site mutation was excluded in all 1,135 individuals (from
the 1000 Genomes Project) for whom the genotype could
be confidently called.
Affected individuals from two families (AI-102 and
AI-103 [Figure S1]) from the United States were found
to be compound heterozygotes for a nonsense changeThe American(c.318G>A [p.Trp106*]) and an indel creating a frame-
shift and premature termination (c.51_56delGGTAACins
ATGCTGGTTACTGGTA [p.Val18Cysfs*23]). Affected indi-
viduals from another family from the United States
(AI-108 [Figure S1]) were found to be homozygous for the
same indel (c.51_56delGGTAACinsATGCTGGTTACTG
GTA [p.Val18Cysfs*23]). Both the c.318G>A variant and
the c.51_56delGGTAACinsATGCTGGTTACTGGTA variant
were absent from 91 control individuals of European
descent. Upon the calling of 1000 Genomes sample geno-
types for the nonsense mutation (c.318G>A [p.Trp106*]),
all 1,133 sample genotypes with a minimum genotype
phred quality score of 30 were homozygous for the refer-
ence base. This variant has been identified in the heterozy-
gous state in 2 of 10,758 chromosomes sequenced by the
National Heart, Lung, and Blood Institute (NHLBI) Exome
Sequencing Project (Exome Variant Server, NHLBI Exome
Sequencing Project, Seattle, WA) and has been given the
dbSNP identifier rs146645381. The indel variant was not
identified in 1,197 individuals for whom a genotype could
be called (these individuals include 1,139 samples with
a minimum genotype phred quality score of 30), although
it should be noted that a complex indel such as this might
be considered unlikely to align and be detected with clonal
sequencing methods.
In total, we identified nine families affected by five
unique mutations in C4orf26. In each case, the mutations
segregated as would be expected for recessively inherited
AI and appear to represent rare variation. The identifica-
tion of nine families affected by C4orf26 mutations indi-
cates discovery of a potential major cause of recessive AI.
We note that individuals with 4q syndrome sometimes
present with enamel defects. However, because indi-
viduals with heterozygous C4orf26 mutations in our
study do not have a defect in enamel mineralization, we
consider it unlikely that deletion of one copy of the
gene would result in an enamel deficiency without muta-
tion of the remaining allele. With the possible exception
of a reported case with del(4)(q21.1q21.3),24 haploinsuffi-
ciency of either ENAM or DSPP (MIM 125485), which are
mutated in dominantly inherited conditions, appears
more likely to be responsible for enamel defects ob-
served in individuals with deletions of the long arm of
chromosome 4.
After the identification of mutations in C4orf26
(RefSeq NM_178497.3), a further RefSeq transcript
(NM_001206981.1) that includes an additional exon re-
sulting in a frameshift was reported. The two encoded
proteins share only the first 22 residues and bear no simi-
larity throughout the length of the remaining sequences.
Putative protein orthologs for this second transcript could
only be identified in Pan troglodytes and Nomascus leucoge-
nys. Although the splice-site mutation (c.68-2A>T) and
indel mutation (c.51_58delGGTAACTGinsATGCTGGTTA
CTGGTATG) identified in AI-affected families are likely to
result in loss of function or truncation of this addi-
tional gene product, the remaining truncating mutationsJournal of Human Genetics 91, 565–571, September 7, 2012 567
Figure 3. C4orf26 mutations
(A–E) Representative electropherograms for C4orf26 mutations uncovered in AI-affected families.
(F) Schematic representation of human C4orf26 protein. Sequence changes found in AI-affected families are marked by vertical arrows.
Predicted phosphorylated sites are shown as red circles. Shading indicates the predicted signal peptide (gray), two conserved motifs
(green and light blue), and the C-terminal peptide (dark and light blue) used in HA-nucleation experiments.identified in NM_178497.3 result in synonymous or
missense variation in NM_001206981.1. It is thus unclear
whether this latter transcript plays any role in amelogene-
sis or has any functional similarity to NM_178497.3.
To confirm expression of C4orf26 during amelogenesis,
we screened cDNA obtained from a continually erupting
rat incisor enamel organ by using RT-PCR. The rat ortholog
was identified by comparison of the alignment of the
mouse ortholog (Gm1045) with the rat genome (Baylor
3.4) and splice-site prediction with NetGene2.25 The pre-
dicted gene was subsequently found to correspond with568 The American Journal of Human Genetics 91, 565–571, SeptembCONTRAST26 prediction CONTRAST.chr14.175. The rat
ortholog was clearly expressed in both secretory- and
maturation-stage enamel organs (Figure 4A and data not
shown) and was not expressed in the rat heart, kidney, or
spleen. In a panel of 20 human tissues, not including the
enamel organ, expression was most obvious in the
placenta (Figure S2). Family AI-46 is large with no history
of premature placental failure.
C4orf26 encodes a 130 amino acid protein with a pre-
dicted signal peptide (residues 1–23) but no other recogniz-
able domains or motifs. Protein-protein BLAST resultser 7, 2012
Figure 4. Expression and Functional Characterization of C4orf26
(A) RT-PCR demonstrating expression of the rat ortholog of C4orf26 in the enamel organ; band identity is confirmed by sequencing.
(B) Representative in vitro mineralization data showing themass of phosphate precipitated with no peptide (negative control), the poly-
glutamic-acid positive control, and nonphosphorylated and phosphorylated peptides corresponding to the C-terminal 30 residues of
C4orf26. Data (n ¼ 6) were analyzed with an unpaired one-tailed Student’s t test. ****p < 0.0001. The following abbreviation is used:
ns, not significant.indicate that C4orf26 is conserved in mammals. Two
motifs, TDCQ[IV][FL]TLTPPP (residue 41–52 of human
NP_848592.2) and R[RG][RQNK]xx[RSG][GD]SSSEE (re-
sidue 118–130 of NP_848592.2) are strongly conserved
(Figure S3).
Sequence analysis with NetPhos 2.027 predicts C4orf26
to be an acidic phosphoprotein containing ten possible
phosphorylation sites resulting in a predicted isoelectric
point of 6.6. Prediction with NetPhos 2.0 suggests that
phosphorylation of the cluster of three C-terminal serine
residues is conserved in mammalian orthologs. Acidic
phosphoproteins promote HAnucleation28 across a diverse
range of biomineralized tissues, yet at high concentrations,
they inhibit crystal growth.29 It is also notable that
C4orf26 has a high proline content of 14.6%, which is
reminiscent of other known enamel-matrix proteins:
ENAM, AMBN, ODAM, AMTN, and AMELX.
We investigated the mineral-nucleation potential of
synthetic peptides corresponding to the predicted phos-
phorylated C terminus of C4orf26 (residues 101–130) by
using a steady-state in vitro nucleation assay carried
out in modified equilibrium dialysis cells as described
previously.30 Phosphorylated C4orf26 (Cys-Phe-Gln-Pro-
Phe-Tyr-Trp-Pro-His-Arg-Tyr-Leu-(p)Thr-Tyr-Arg-Tyr-Phe-
Pro-Arg-Arg-Arg-Leu-Gln-Arg-Gly-(p)Ser-(p)Ser-(p)Ser-Glu-
Glu-Ser) and the corresponding nonphosphorylated
peptide (Eurogentec, Southampton, UK) were dissolved
at 7 mM (~30 mg/ml) in 1% agarose solution containing
20 mM HEPES and 150 mM NaCl (pH 7.4) at 37C. Pol-
yglutamic acid (Sigma, Poole, UK) dissolved in the same
buffered agarose at a concentration of 10 mg/ml was
used as a positive control, and buffered agarose contain-
ing no peptide was used as negative control. The
peptide/agarose solutions were poured into the central
cavities of the modified dialysis cells and were allowed
to set at room temperature. Dialysis cells were connected
in parallel, and a peristaltic pump was used for pumpingThe Americancalcium-containing buffer (20 mM HEPES, 150 mM NaCl,
and 6.5 mMCa(NO3).4H2O at pH 7.4) through the dialysis
cell reservoirs in contact with one side of the agarose plugs,
whereas phosphate-containing buffer (20 mM HEPES,
150 mM NaCl, and 3.9 mM Na2HPO4.2H2O at pH 7.4)
was pumped in contra flow direction through the adjacent
reservoirs in contact with the other side of the agarose
plugs. The buffers were pumped continuously at a flow
rate of 1 ml/hr/cell at 37C for 7 days. During this period,
calcium and phosphate ions diffuse from opposite ends of
the agarose plugs and mineral precipitates in the gels to
a degree dependent on the nucleating potential of the
peptides present. We quantified mineral precipitation
in the plugs by determining phosphate concentration in
each plug by using the phosphomolybdate method.30
These experiments showed that phosphorylated peptide
was able to promote HA nucleation and support crystal
growth, whereas the nonphosphorylated peptide showed
no such activity (Figure 4B).
Posteruptive enamel loss is rapid in AI as a result of
C4orf26 mutations, and there are obvious abnormalities
on scanning electron microscopy.31 Transmission electron
microscopy (Figure S5) reveals thin crystallites reminiscent
of those normally found in the secretory and early-matura-
tion stages of enamel formation prior to final maturation,
where crystallites grow in width and thickness until the
tissue volume is occluded. The presence of crystallites in
C4orf26-linked AI suggests that HA nucleation is not the
key role of C4orf26 in amelogenesis but that it does influ-
ence crystallite growth. C4orf26’s predicted export peptide
signal and similarities with known enamel-matrix extracel-
lular proteinsmight reflect roles in the control of crystallite
growth within the developing enamel matrix.
In conclusion, although the precise role of C4orf26 will
require further experimental exploration, the discovery of
mutations as a major cause of AI and the ability of a phos-
phorylated peptide to promote HA nucleation and crystalJournal of Human Genetics 91, 565–571, September 7, 2012 569
growth in vitro offer new insights into biomineralization.
This is relevant not only to this poorly understood group
of clinical conditions that have a profoundly nega-
tive impact on affected individuals but also for the
development of biomimetic materials with wide-ranging
applications.Supplemental Data
Supplemental Data include five figures and three tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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